As many as 100,000 patients had a cancer that was missed, or had their diagnoses or treatments delayed during the lockdowns of 2020 and 2021. That’s the shocking finding of a recent study by the Institute of Cancer Policy at King’s College London.
The experts conclude that some patients will already have died, many still haven’t been diagnosed and others will already have a more advanced cancer as a result of the delays.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in